Description
Agilent Technologies’ Hidden Growth Story: China Revenue Jumps 9%!
Agilent Technologies, Inc. reported a strong third quarter for fiscal 2026, with revenue reaching $1.88 billion and core year-over-year growth of 7.3%, exceeding guidance by 140 basis points. The company’s operating margin, excluding a $20 million tariff refund benefit, came in at 27.2%, surpassing expectations by 80 basis points. On an ex-refund basis, earnings per share (EPS) were $1.56, reflecting a 14% increase over the prior year and beating the high end of guidance by six cents. Including tariff refunds, EPS stood at $1.62. The company’s strong commercial execution, innovation efforts, and operational improvements driven by its Ignite Operating System were noted as key contributors to this performance. Pharmaceutical end markets showed robust 12% growth, particularly driven by biotech and small molecule segments, alongside a nearly 30% increase in the Advanced Therapeutics Division, which includes specialty CDMO operations.
